84
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Analytical Performance Evaluation of Three Commercial Rapid Nucleic Acid Assays for SARS-CoV-2

, , , , &
Pages 3169-3174 | Published online: 14 Aug 2021

References

  • LiQ, GuanX, WuP, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa200131631995857
  • MunsterVJ, KoopmansM, van DoremalenN, van RielD, de WitE. A novel coronavirus emerging in China - key questions for impact assessment. N Engl J Med. 2020;382(8):692–694. doi:10.1056/NEJMp200092931978293
  • LoeffelholzMJ, TangYW. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect. 2020;9(1):747–756. doi:10.1080/22221751.2020.174509532196430
  • MathuriaJP, YadavR. Laboratory diagnosis of SARS-CoV-2 - A review of current methods. J Infect Public Health. 2020;13(7):901–905. doi:10.1016/j.jiph.2020.06.00532534946
  • LiuR, HanH, LiuF, et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta. 2020;505:172–175. doi:10.1016/j.cca.2020.03.00932156607
  • LandaasET, StormML, TollånesMC, et al. Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort. J Clin Virol. 2021;137:104789. doi:10.1016/j.jcv.2021.10478933736946
  • DiaoB, WenK, ZhangJ, et al. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection. Clin Microbiol Infect. 2021;27(2):289.e1–289.e4. doi:10.1016/j.cmi.2020.09.057
  • Trobajo-SanmartínC, NavascuésA, MiqueleizA, EzpeletaC. Evaluation of the rapid antigen test CerTest SARS-CoV-2 as an alternative COVID-19 diagnosis technique. Infect Dis. 2021;53(9):730–732. doi:10.1080/23744235.2021.1902563
  • IglὁiZ, VelzingJ, van BeekJ, et al. Clinical evaluation of Roche SD biosensor rapid antigen test for SARS-CoV-2 in municipal health service testing site, the Netherlands. Emerg Infect Dis. 2021;27(5):1323–1329. doi:10.3201/eid2705.20468833724916
  • TakeuchiY, AkashiY, KatoD, et al. The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: a prospective observational study in Japan. J Infect Chemother. 2021;27(6):890–894. doi:10.1016/j.jiac.2021.02.02933727026
  • StokesW, BerengerBM, PortnoyD, et al. Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19. Eur J Clin Microbiol Infect Dis. 2021;40(8):1721–1726. doi:10.1007/s10096-021-04202-933742322
  • KostGJ. Molecular and point-of-care diagnostics for Ebola and new threats: national POCT policy and guidelines will stop epidemics. Expert Rev Mol Diagn. 2018;18(7):657–673. doi:10.1080/14737159.2018.149179329933717
  • SiekerJT, HorowitzC, HuCK, et al. Analytic sensitivity of 3 nucleic acid detection assays in diagnosis of SARS-CoV-2 infection. J Appl Lab Med. 2021;6(2):421–428. doi:10.1093/jalm/jfaa18733674879
  • XiaoY, LiZ, WangX, et al. Comparison of three TaqMan real-time reverse transcription-PCR assays in detecting SARS-CoV-2. J Virol Methods. 2021;288:114030. doi:10.1016/j.jviromet.2020.11403033275927
  • BisoffiZ, PomariE, DeianaM, et al. Sensitivity, specificity and predictive values of molecular and serological tests for COVID-19: a longitudinal study in emergency room. Diagnostics. 2020;10(9). doi:10.3390/diagnostics10090669
  • JarvisKF, KelleyJB. Temporal dynamics of viral load and false negative rate influence the levels of testing necessary to combat COVID-19 spread. Sci Rep. 2021;11(1):9221. doi:10.1038/s41598-021-88498-933911131
  • KrajewskiR, GołębiowskaJ, MakuchS, MazurG, AgrawalS. Update on serologic testing in COVID-19. Clin Chim Acta. 2020;510:746–750. doi:10.1016/j.cca.2020.09.01532946795
  • LiuR, LiuX, YuanL, et al. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis. Int Immunopharmacol. 2020;86:106746. doi:10.1016/j.intimp.2020.10674632619956
  • LiuW, LiuL, KouG, et al. Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. J Clin Microbiol. 2020;58(6). doi:10.1128/JCM.00461-20
  • ShragaiT, Smith-JeffcoatSE, KohM, et al. Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing. J Infect Dis. 2021. doi:10.1093/infdis/jiab349